Global Whole Exome Sequencing Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Whole Exome Sequencing market size will reach 438.68 Million USD in 2025 and is projected to reach 897.64 Million USD by 2032, with a CAGR of 10.77% (2025-2032). Notably, the China Whole Exome Sequencing market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Whole exome sequencing (WES) is a cutting-edge genomic technique used to analyze the protein-coding regions of an individual＇s genome, known as the exome. The exome represents only about 1-2% of the entire genome but contains the majority of disease-causing mutations. WES involves capturing and sequencing the DNA fragments corresponding to these exons using high-throughput sequencing technologies. By sequencing the exome, researchers and clinicians can identify genetic variations, mutations, and alterations that may be associated with various diseases, disorders, or conditions. WES is particularly useful for identifying rare genetic diseases, elucidating the genetic basis of inherited disorders, and guiding personalized medicine approaches, such as targeted therapies or precision medicine. It offers a comprehensive and cost-effective approach to genomic analysis, providing valuable insights into the genetic underpinnings of human health and disease.
The major global suppliers of Whole Exome Sequencing include Illumina, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen, BGI, Novo Gene, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Whole Exome Sequencing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Whole Exome Sequencing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Whole Exome Sequencing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Whole Exome Sequencing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Whole Exome Sequencing Include:
Illumina
Thermo Fisher
Roche
Angilent
Eurofins
Sengenics
Ambry
Macrogen
BGI
Novo Gene
Whole Exome Sequencing Product Segment Include:
Agilent HaloPlex
Agilent SureSelect
Agilent SureSelect QXT
Illumina TruSeq Exome
Roche Nimblegen SeqCap
MYcroarray MYbaits
Whole Exome Sequencing Product Application Include:
Correlation Research of Normal Human
Mendelian Disease and Rare Syndrome Gene Discovery
The Research of Complex Diseases
Mouse Exome Sequencing
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Whole Exome Sequencing Industry PESTEL Analysis
Chapter 3: Global Whole Exome Sequencing Industry Porter's Five Forces Analysis
Chapter 4: Global Whole Exome Sequencing Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Whole Exome Sequencing Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Whole Exome Sequencing Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Whole Exome Sequencing Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Whole Exome Sequencing market size will reach 438.68 Million USD in 2025 and is projected to reach 897.64 Million USD by 2032, with a CAGR of 10.77% (2025-2032). Notably, the China Whole Exome Sequencing market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Whole exome sequencing (WES) is a cutting-edge genomic technique used to analyze the protein-coding regions of an individual＇s genome, known as the exome. The exome represents only about 1-2% of the entire genome but contains the majority of disease-causing mutations. WES involves capturing and sequencing the DNA fragments corresponding to these exons using high-throughput sequencing technologies. By sequencing the exome, researchers and clinicians can identify genetic variations, mutations, and alterations that may be associated with various diseases, disorders, or conditions. WES is particularly useful for identifying rare genetic diseases, elucidating the genetic basis of inherited disorders, and guiding personalized medicine approaches, such as targeted therapies or precision medicine. It offers a comprehensive and cost-effective approach to genomic analysis, providing valuable insights into the genetic underpinnings of human health and disease.
The major global suppliers of Whole Exome Sequencing include Illumina, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen, BGI, Novo Gene, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Whole Exome Sequencing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Whole Exome Sequencing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Whole Exome Sequencing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Whole Exome Sequencing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Whole Exome Sequencing Include:
Illumina
Thermo Fisher
Roche
Angilent
Eurofins
Sengenics
Ambry
Macrogen
BGI
Novo Gene
Whole Exome Sequencing Product Segment Include:
Agilent HaloPlex
Agilent SureSelect
Agilent SureSelect QXT
Illumina TruSeq Exome
Roche Nimblegen SeqCap
MYcroarray MYbaits
Whole Exome Sequencing Product Application Include:
Correlation Research of Normal Human
Mendelian Disease and Rare Syndrome Gene Discovery
The Research of Complex Diseases
Mouse Exome Sequencing
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Whole Exome Sequencing Industry PESTEL Analysis
Chapter 3: Global Whole Exome Sequencing Industry Porter's Five Forces Analysis
Chapter 4: Global Whole Exome Sequencing Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Whole Exome Sequencing Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Whole Exome Sequencing Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Whole Exome Sequencing Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Whole Exome Sequencing Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Whole Exome Sequencing Product by Type
- 1.2.1 Agilent HaloPlex
- 1.2.2 Agilent SureSelect
- 1.2.3 Agilent SureSelect QXT
- 1.2.4 Illumina TruSeq Exome
- 1.2.5 Roche Nimblegen SeqCap
- 1.2.6 MYcroarray MYbaits
- 1.3 Whole Exome Sequencing Product by Application
- 1.3.1 Correlation Research of Normal Human
- 1.3.2 Mendelian Disease and Rare Syndrome Gene Discovery
- 1.3.3 The Research of Complex Diseases
- 1.3.4 Mouse Exome Sequencing
- 1.4 Global Whole Exome Sequencing Market Size Analysis (2020-2032)
- 1.5 Whole Exome Sequencing Market Development Status and Trends
- 1.5.1 Whole Exome Sequencing Industry Development Status Analysis
- 1.5.2 Whole Exome Sequencing Industry Development Trends Analysis
- 2 Whole Exome Sequencing Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Whole Exome Sequencing Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Whole Exome Sequencing Market Analysis by Country
- 4.1 Global Whole Exome Sequencing Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Whole Exome Sequencing Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Whole Exome Sequencing Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Whole Exome Sequencing Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Whole Exome Sequencing Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Whole Exome Sequencing Market Revenue and Growth Rate (2020-2032)
- 4.5 China Whole Exome Sequencing Market Revenue and Growth Rate (2020-2032)
- 4.6 France Whole Exome Sequencing Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Whole Exome Sequencing Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Whole Exome Sequencing Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Whole Exome Sequencing Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Whole Exome Sequencing Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Whole Exome Sequencing Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Whole Exome Sequencing Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Whole Exome Sequencing Market Revenue and Growth Rate (2020-2032)
- 4.14 India Whole Exome Sequencing Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Whole Exome Sequencing Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Whole Exome Sequencing Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Whole Exome Sequencing Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Whole Exome Sequencing Market Revenue by Key Suppliers (2021-2025)
- 5.2 Global Whole Exome Sequencing Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Whole Exome Sequencing Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Whole Exome Sequencing Market Analysis by Type
- 6.1 Global Whole Exome Sequencing Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Whole Exome Sequencing Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Illumina
- 7.1.1 Illumina Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Illumina Whole Exome Sequencing Product Portfolio
- 7.1.3 Illumina Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Thermo Fisher
- 7.2.1 Thermo Fisher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Thermo Fisher Whole Exome Sequencing Product Portfolio
- 7.2.3 Thermo Fisher Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Roche
- 7.3.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Roche Whole Exome Sequencing Product Portfolio
- 7.3.3 Roche Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Angilent
- 7.4.1 Angilent Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Angilent Whole Exome Sequencing Product Portfolio
- 7.4.3 Angilent Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Eurofins
- 7.5.1 Eurofins Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Eurofins Whole Exome Sequencing Product Portfolio
- 7.5.3 Eurofins Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Sengenics
- 7.6.1 Sengenics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Sengenics Whole Exome Sequencing Product Portfolio
- 7.6.3 Sengenics Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Ambry
- 7.7.1 Ambry Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Ambry Whole Exome Sequencing Product Portfolio
- 7.7.3 Ambry Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Macrogen
- 7.8.1 Macrogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Macrogen Whole Exome Sequencing Product Portfolio
- 7.8.3 Macrogen Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 BGI
- 7.9.1 BGI Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 BGI Whole Exome Sequencing Product Portfolio
- 7.9.3 BGI Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Novo Gene
- 7.10.1 Novo Gene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Novo Gene Whole Exome Sequencing Product Portfolio
- 7.10.3 Novo Gene Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Whole Exome Sequencing Industry Chain Analysis
- 8.2 Whole Exome Sequencing Product Downstream Application Analysis
- 8.2.1 Global Whole Exome Sequencing Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Whole Exome Sequencing Revenue and Forecast by Application (2020-2032)
- 8.3 Whole Exome Sequencing Typical Downstream Customers
- 8.4 Whole Exome Sequencing Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
